Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

Trial Profile

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 16 Feb 2016

At a glance

  • Drugs K 312 (Primary)
  • Indications Hyperlipidaemia
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Kowa Research Institute
  • Most Recent Events

    • 16 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top